Literature DB >> 22464341

Personalised antiplatelet treatment: a RAPIDly moving target.

Amber L Beitelshees1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22464341     DOI： 10.1016/S0140-6736(12)60431-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.

Authors:  Adrian Towse; Diego Ossa; David Veenstra; Josh Carlson; Louis Garrison
Journal:  J Pers Med       Date:  2013-10-25

Review 2.  Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?

Authors:  Loredana Iannetta; Paolo Emilio Puddu; Domenico Cuturello; Angela Saladini; Mariano Pellicano; Michele Schiariti
Journal:  Cardiol Res       Date:  2013-03-08

3.  Put to the test: For a new sociology of testing.

Authors:  Noortje Marres; David Stark
Journal:  Br J Sociol       Date:  2020-04-19

Review 4.  Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?

Authors:  Christina G Perry; Alan R Shuldiner
Journal:  J Hum Genet       Date:  2013-05-23       Impact factor: 3.172
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.